•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.The Big Winner From the Aurora Cannabis-Organigram Deal: Curaleaf
Aurora Cannabis Inc. (ACB) Q2 Earnings and Revenues Top Estimates
Aurora Cannabis Announces Fiscal 2027 Second Quarter Results
Aurora Cannabis Stock: What Organigram's Buyout Means for Investors
Curaleaf Issues Statement Regarding Alternative Proposal for Aurora Cannabis
Organigram to Acquire Aurora and Establish a Global Cannabis Leader
Organigram to Acquire Aurora and Establish a Global Cannabis Leader
Organigram outbids Curaleaf with C$561M deal for Aurora Cannabis
Sigma Lithium upsizes convertible bond offering to $125 million
Aurora Cannabis to Host Second Quarter 2027 Investor Conference Call
ACB's Q2 Earnings on Deck: International Medical Cannabis in Focus
Aurora Cannabis Announces the Alberta Securities Commission has dismissed Curaleaf's Application and ruled in favour of the Company's At-the-Market Program
Aurora Rejects Curaleaf's Higher Bid, But the Takeover Fight Isn't Over
Aurora Cannabis Reaffirms Recommendation to Shareholders: REJECT Curaleaf's Revised Hostile Bid; Preserve Opportunities for Future Upside
Aurora Cannabis Stock Has Soared 25% Since Curaleaf First Made an Offer to Buy Its Business. Here's Why I Think It Can Go Even Higher
Comparing Aurora Cannabis (NASDAQ:ACB) & BeOne Medicines (NASDAQ:ONC)
Tilray Brands Sinks 4% as Record Revenue Masks Shrinking Cannabis Sales; Canopy Growth and Aurora Cannabis Ease
Aurora Completes Major Expansion of European EU-GMP Manufacturing Facility, More Than Doubling Expected Annual Flower Output
Aurora Urges Shareholders to Take No Action to Revised Hostile Bid by Curaleaf as Formal Review Underway
Curaleaf's Higher Aurora Bid Raises the Stakes in Cannabis Consolidation
Already premium?